E71.520 Childhood cerebral X-linked adrenoleukodystrophy

Name of the Condition

• Childhood cerebral X-linked adrenoleukodystrophy

Summary

Childhood cerebral X-linked adrenoleukodystrophy is a severe form of X-linked adrenoleukodystrophy (X-ALD) that primarily affects the nervous system in children. It results from the accumulation of very long-chain fatty acids (VLCFAs), leading to progressive damage to the myelin sheath around nerve cells and neurological deterioration.

Causes

This condition is caused by mutations in the ABCD1 gene on the X chromosome. The mutation disrupts the breakdown of VLCFAs, causing them to accumulate in tissues and damage the nervous system and adrenal glands.

Risk Factors

• Being male, as the condition is X-linked.
• Family history of X-ALD due to its hereditary nature.

Symptoms

• Progressive neurological deterioration.
• Adrenal insufficiency (Addison's disease).
• Behavioral changes, weakness, and spasticity.
• Loss of vision, hearing, and mobility in severe cases.

Diagnosis

Diagnosis involves blood tests to measure VLCFA levels, genetic testing to identify ABCD1 gene mutations, and MRI scans to detect changes in brain structures.

Treatment Options

• Corticosteroid replacement therapy: For adrenal insufficiency.
• Lorenzo's oil: To help normalize VLCFA levels, although effectiveness varies.
• Hematopoietic stem cell transplantation (HSCT): Stops disease progression in cerebral ALD if performed early.

Prognosis and Follow-Up

Prognosis is poor without early intervention, as the condition progresses rapidly. Regular follow-up includes monitoring neurological function, adrenal hormone levels, and VLCFA levels to assess treatment response.

Complications

• Severe neurological impairment.
• Adrenal crisis due to untreated adrenal insufficiency.
• Loss of motor and sensory function.

Lifestyle & Prevention

• Genetic counseling for families with a history of X-ALD.
• Early detection through newborn screening in some regions.

When to Seek Professional Help

Seek immediate medical attention for symptoms like unexplained weakness, behavioral changes, or signs of adrenal insufficiency (e.g., fatigue, low blood pressure).

Tips for Medical Coders

Document the presence of neurological symptoms, adrenal insufficiency, and genetic testing results. Ensure the code E71.520 is used when the condition is specified as childhood cerebral X-linked adrenoleukodystrophy.